XENVERZY
Live / Applied — Fourth extension granted (statement of use) (as of 17 Jul 2025)
What this means for you
Not registered yet, but its 12 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97500212
- Mark type
- Stylized text
- Filed
- 12 Jul 2022
- Published for opposition
- 06 Jun 2023
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases
Owner
- ZENTALIS PHARMACEUTICALS, INC., San Diego, CA, US
- ZENTALIS PHARMACEUTICALS, INC., San Diego, CA, US
Prosecution history
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 4 GRANTED
- 17 Jul 2025 — SOU EXTENSION 4 FILED
- 17 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2025 — SOU EXTENSION 3 GRANTED
- 25 Jan 2025 — SOU EXTENSION 3 FILED
- 24 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2024 — SOU EXTENSION 2 GRANTED
- 01 Aug 2024 — SOU EXTENSION 2 FILED
- 01 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Feb 2024 — SOU EXTENSION 1 GRANTED